NCT01539915View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

November 30, 2007

Conditions
Psoriasis
Interventions
DRUG

BCT194

Topically applied BCT194 cream (0.5%)

Trial Locations (1)

Unknown

Novartis Investigative Site, Graz

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY